| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | -0.09 | 0.002 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.089 | 0.002 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.089 | 0.003 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.23 | 0.003 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.094 | 0.003 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | -0.092 | 0.003 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.16 | 0.003 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |